<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE UNAUDITED NOVAMETRIX MEDICAL SYSTEMS INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME FOR THE NINE MONTHS ENDED JANUARY 30, 2000 AND THE CONDENSED CONSOLIDATED BALANCE SHEETS AT JANUARY 30, 2000, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> APR-30-2000 <PERIOD-END> JAN-30-2000 <CASH> 224,531 <SECURITIES> 0 <RECEIVABLES> 15,531,299 <ALLOWANCES> (300,000) <INVENTORY> 10,906,140 <CURRENT-ASSETS> 27,520,436 <PP&E> 11,606,528 <DEPRECIATION> (8,073,635) <TOTAL-ASSETS> 46,804,506 <CURRENT-LIABILITIES> 12,142,950 <BONDS> 8,490,983 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 94,236 <OTHER-SE> 26,076,337 <TOTAL-LIABILITY-AND-EQUITY> 46,804,506 <SALES> 30,360,284 <TOTAL-REVENUES> 30,360,284 <CGS> 12,794,919 <TOTAL-COSTS> 12,794,919 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 756,322 <INCOME-PRETAX> 2,120,771 <INCOME-TAX> 679,100 <INCOME-CONTINUING> 1,441,671 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> (223,544) <NET-INCOME> 1,218,127 <EPS-BASIC> .15 <EPS-DILUTED> .15